Drug-Coated Balloons in the European Registry of Chronic Total Occlusion
JACC: Cardiovascular Interventions · 2025-09 · 18 (18) · 2209-2221
DOI: 10.1016/j.jcin.2025.07.036 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-09. Verfasst von Niccolò Ciardetti und 25 weiteren Autor:innen. Beteiligte Einrichtung: Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy. Hauptthemen laut MEDLINE: Coronary Occlusion, Coated Materials, Biocompatible, Cardiac Catheters, Angioplasty, Balloon, Coronary. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Drug-coated balloons (DCBs) are increasingly used in percutaneous coronary intervention (PCI). Their application for chronic total occlusions (CTOs) is a promising option to limit stent length in diffuse disease and avoid stent underexpansion and malapposition in negatively remodeled distal vessel segments. OBJECTIVES: The aim of this study was to analyze CTO PCI procedures recorded in ERCTO (European Registry of Chronic Total Occlusion) to investigate frequency of use, patient and lesion characteristics, and in-hospital outcomes of DCBs. METHODS: CTO cases entered into the database from 2016 to 2023 were examined and categorized according to DCB use. DCB-treated patients were further divided into 2 groups: DCBs only and DCBs in association with drug-eluting stents. To minimize the potential impact of confounding factors, 1:1 propensity score matching was applied. RESULTS: Of 40,449 CTO PCIs performed at 184 centers, DCBs were used in 2,506 (6.2%), increasing from 3.4% (n = 185 of 5,498) in 2016 to 14.9% (n = 705 of 4,722) in 2023. In-hospital complications were infrequent, but DCB-treated CTOs had significantly lower rates of pericardial tamponade (0.1% [n = 2 of 2,506] vs 0.4% [n = 169 of 37,943]; P = 0.006). After propensity score matching, DCB use led to reduced drug-eluting stent length (44.2 ± 36.9 mm [95% CI: 42.7-45.7 mm] vs 58.1 ± 35.9 mm [95% CI: 56.7-59.5] mm; P < 0.001). Contrast volume was lower in the DCB-treated patients (202.4 ± 109.8 mL [95% CI: 198.1-206.7 mL] vs 211.6 ± 123 mL [95% CI: 206.8-216.4 mL]; P = 0.005). CONCLUSIONS: The use of DCBs in CTO recanalization is increasing and is associated with a reduction in the length of stents implanted, as well as a decrease in contrast volume and a lower rate of pericardial tamponade.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.
- Klinikum Darmstadt, Darmstadt, Germany.
- Department of Cardiology and Angiolgy, DRK Kliniken Berlin Köpenick, Berlin, Germany.
- Mediclin Heart Center Lahr, Lahr, Germany.
- Haaglanden MC, the Hague, the Netherlands.
- University Heartcenter Bad Oeynhausen, Bad Oeynhausen, Germany.
Zitieren
APA
Ciardetti, N., Mattesini, A., Werner, G. S., Atmowihardjo, I., Zaczkiewicz, M., Bas, S., Ayoub, M., Ladwiniec, A., Weber-Albers, J., Lauer, B., Kovacic, M., Prog, R., Rathore, S., Behnes, M., Diletti, R., Goktekin, O., Avran, A., Boudou, N., Christiansen, E. H., …, & Euro CTO Investigators (2025). Drug-Coated Balloons in the European Registry of Chronic Total Occlusion. JACC: Cardiovascular Interventions, 18(18), 2209-2221. https://doi.org/10.1016/j.jcin.2025.07.036
Vancouver
Ciardetti N, Mattesini A, Werner GS, Atmowihardjo I, Zaczkiewicz M, Bas S, et al. Drug-Coated Balloons in the European Registry of Chronic Total Occlusion. JACC: Cardiovascular Interventions. 2025;18(18):2209-2221. doi:10.1016/j.jcin.2025.07.036
BibTeX
@article{Ciardetti2025,
author = {Ciardetti, Niccolò and Mattesini, Alessio and Werner, Gerald S and Atmowihardjo, Iskandar and Zaczkiewicz, Myron and Bas, Schölzel and Ayoub, Mohamed and Ladwiniec, Andrew and Weber-Albers, Joachim and Lauer, Bernward and Kovacic, Mihajlo and Prog, Rostislav and Rathore, Sudhir and Behnes, Michael and Diletti, Roberto and Goktekin, Omer and Avran, Alexander and Boudou, Nicolas and Christiansen, Evald H and Pyxaras, Stylianos A and Gutierrez Chico, Juan Luis and Agostoni, Pierfrancesco and Calò, Alessandro and Mashayekhi, Kambis and Di Mario, Carlo and Euro CTO Investigators, Euro CTO Investigators},
title = {Drug-Coated Balloons in the European Registry of Chronic Total Occlusion},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {18},
pages = {2209--2221},
doi = {10.1016/j.jcin.2025.07.036}
}
EUVIMED